Private-label usually starts as a cost conversation. A branded product often costs more. A private-label option often costs less. On paper, both generally meet the spec. So why pay extra?
AI Made Healthcare Smarter – The Next Step is Making It Simpler
There is no shortage of innovation in healthcare. But what has been surprising is that despite all the innovation, it is still very difficult to navigate the healthcare system as
AI Is Becoming the Front Door to Healthcare — But Millions of Patients Can’t Get Through It
Pay attention to health tech for even a few weeks and you’ll spot the pattern. Amazon expanded its AI health assistant to anyone on its app or website. Microsoft rolled
Smarter Engagement for Stronger Growth: How Payers Can Successfully Do More with Less
Imagine two members receiving a message from their health plan on the same day. One is a 75-year-old Spanish-speaking man managing multiple chronic conditions. The other is a 30-year-old pregnant
Workforce of the Future: Supporting Frontline Heroes
The future of long-term care and rehabilitation will be determined by how intentionally we design systems around them. Too many organizations still treat workforce strain as a support issue when,
AI in Digital Health, From Early Detection to Responsible Deployment
AI is everywhere in healthcare conversations right now, most of that discussion still sits at a high level. The real work is happening much closer to the ground, inside clinical
What Trends Are Shaping the Dental and Vision Benefits Market?
When it comes to health benefits, more attention has always been given to medical, compared with dental and vision. And yet, there is a growing recognition that oral health is
Takeda Vows Appeal of $885M Jury Verdict in ‘Pay-for-Delay’ Antitrust Case
Most disputes between pharmaceutical companies and generic drugmakers end in settlements. Five years of class-action litigation over a Takeda Pharmaceutical gastrointestinal drug culminated this week in a jury awarding nearly $885
Hospitals Take CVS to Court Over Alleged $250M 340B Scheme
Three health systems are suing CVS Health, alleging the company and its pharmacy subsidiaries diverted roughly $250 million in savings from the 340B Drug Pricing Program. The health systems —
Timing Meets Context: Aligning Patients and Providers with AI-Enabled Omnichannel Engagement
In modern healthcare, brand conversion stems from timing and context. Today’s AI-enabled communication technologies help healthcare organizations deliver timely, privacy-safe awareness messages that ensure patients and clinicians encounter relevant information









